264 related articles for article (PubMed ID: 18088156)
1. Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.
Anonychuk AM; Tricco AC; Bauch CT; Pham B; Gilca V; Duval B; John-Baptiste A; Woo G; Krahn M
Pharmacoeconomics; 2008; 26(1):17-32. PubMed ID: 18088156
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hepatitis A vaccination in Indonesia.
Suwantika AA; Beutels P; Postma MJ
Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
[TBL] [Abstract][Full Text] [Related]
5. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
[TBL] [Abstract][Full Text] [Related]
6. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
Pan XJ; Feng YM; Zhuang GH
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):862-6. PubMed ID: 22967346
[TBL] [Abstract][Full Text] [Related]
7. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
Das A
Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.
Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP
Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluations of hepatitis A vaccination in middle-income countries.
Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ
Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
Arguedas MR; Heudebert GR; Fallon MB; Stinnett AA
Am J Gastroenterol; 2002 Mar; 97(3):721-8. PubMed ID: 11922569
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
15. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
O'Connor JB; Imperiale TF; Singer ME
Hepatology; 1999 Oct; 30(4):1077-81. PubMed ID: 10498662
[TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature.
Skally M; Hanly P; Sharp L
Appl Health Econ Health Policy; 2013 Jun; 11(3):181-92. PubMed ID: 23549792
[TBL] [Abstract][Full Text] [Related]
19. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
